Cuproptosis In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@tsvetkov2022]
Introduction
Cuproptosis is a recently identified form of regulated cell death driven by copper-dependent proteotoxic stress. Discovered in 2022, this copper-induced cell death mechanism has emerged as a potentially important pathway in neurodegenerative diseases, where copper dyshomeostasis is frequently observed. [@wang2022]
Unlike [apoptosis](/entities/apoptosis) (which is caspase-dependent) or [ferroptosis](/entities/ferroptosis) (which is iron-dependent), cuproptosis is characterized by direct copper binding to lipoylated TCA cycle proteins, leading to proteotoxic stress and cell death. This mechanism may contribute to the neuronal loss observed in Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [@kaler2021]
Molecular Mechanism
Copper-Induced Proteotoxic Stress
flowchart TD
A["Elevated Intracellular Copper"] --> B["Direct Copper Binding"]
B --> C["Lipoylated TCA Cycle Enzymes"]
C --> D["DLAT Oligomerization"]
D --> E["Proteotoxic Stress"]
E --> F["Heat Shock Protein Response"]
F --> G["Cuproptosis"]
H["Copper Chaperones"] --> A
I["ATP7A/ATP7B Dysfunction"] --> A
J["Copper Import via CTR1"] --> A
Key Molecular Players
...
Cuproptosis in Neurodegeneration
Overview
Cuproptosis In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications. [@tsvetkov2022]
Introduction
Cuproptosis is a recently identified form of regulated cell death driven by copper-dependent proteotoxic stress. Discovered in 2022, this copper-induced cell death mechanism has emerged as a potentially important pathway in neurodegenerative diseases, where copper dyshomeostasis is frequently observed. [@wang2022]
Unlike [apoptosis](/entities/apoptosis) (which is caspase-dependent) or [ferroptosis](/entities/ferroptosis) (which is iron-dependent), cuproptosis is characterized by direct copper binding to lipoylated TCA cycle proteins, leading to proteotoxic stress and cell death. This mechanism may contribute to the neuronal loss observed in Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). [@kaler2021]
Interpretation: Moderate-to-high priority target. The mechanistic basis is solid, but delivery to the CNS and safety monitoring remain challenges. Best suited for combination therapy approaches.
Action Plan
Phase 1: Target Validation (Year 1)
Validate cuproptosis markers in patient brain tissue
Identify biomarker panel for patient stratification
Establish copper dyshomeostasis endpoints
Phase 2: Therapeutic Development (Years 2-3)
Repurpose existing chelators for CNS indications
Develop brain-penetrant copper modulators
Test combination therapies (chelation + antioxidants)
[Multi-omic insight into the molecular mechanism of cuproptosis-related genes in the pathogenesis of Parkinson's disease.](https://pubmed.ncbi.nlm.nih.gov/41540060/) (2026 Jan 15) - NPJ Parkinson's disease
[Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities.](https://pubmed.ncbi.nlm.nih.gov/41597186/) (2026 Jan 8) - Cells
[Aging at the Crossroads of Cuproptosis and Ferroptosis: From Molecular Pathways to Age-Related Pathologies and Therapeutic Perspectives.](https://pubmed.ncbi.nlm.nih.gov/41516398/) (2026 Jan 4) - International journal of molecular sciences
[Orchestrating pathogenesis: copper ions as the conductor of molecular dysfunction in Parkinson's disease and therapeutic avenues.](https://pubmed.ncbi.nlm.nih.gov/41772865/) (2026 Mar) - Rev Neurosci
[Polygonatum Sibiricum polysaccharide ameliorates Alzheimer's disease by alleviating cuproptosis and activating the PI3K/AKT signaling pathway.](https://pubmed.ncbi.nlm.nih.gov/41687942/) (2026 May) - J Ethnopharmacol
[Potential targets of microglia in the treatment of neurodegenerative diseases: Mechanism and therapeutic implications.](https://pubmed.ncbi.nlm.nih.gov/40145977/) (2026 Apr) - Neural Regen Res
References
[Tsvetkov et al., Copper induces cell death via targeting lipoylated TCA cycle proteins (2022) (2022)](https://doi.org/10.1126/science.abf0529)
[Wang et al., Copper Metabolism in Neurodegenerative Diseases (2022) (2022)](https://doi.org/10.1007/s12035-022-03050-3)
[Kaler et al., ATP7A and ATP7B in Neurodegeneration (2021) (2021)](https://doi.org/10.1002/jbmr.441)
[Unknown, Trientine for Wilson Disease - FDA Approval (n.d.)](https://pubmed.ncbi.nlm.nih.gov/11418776/)
[Unknown, Tetrathiomolybdate in Neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25964028/)